A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020
Vall d'Hebron Institute of Oncology
Vall d'Hebron Institute of Oncology
National Cancer Institute (NCI)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fate Therapeutics
Fate Therapeutics
Roger Williams Medical Center
Barbara Ann Karmanos Cancer Institute
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)